1. A simple technique has been developed to obtain suboellular fractions of chick bone. The method yielded 60-70% of total DNA in the nuclear debris fraction and 80-90% of total 14C recovered in bone after a dose of radioactive vitamin D. 2. After a dose of [4-14C,1,2-3H2]cholecalciferol (0.5,ug) was given to vitamin D-deficient chicks, the time-course of total 14C radioactivity in the epiphysis, metaphysis and diaphysis of proximal tibiae was measured. The maximum concentrations were reached at 6h, corresponding to a similar peak of radioactivity in blood, decreasing until 24h and indicating the dependence on the circulating 14C and on the blood supply of the three bone components. 3. The 14C radioactivity of cholecalciferol and 25-hydroxycholecalciferol (expressed per mg of DNA) followed the pattem of incorporation of total 14C radioactivity in all three bone components. The more polar metabolite fraction reached a peak of radioactivity at 6-9h and maintained its concentration over the 24h period studied in all anatomical bone components. 4. After a dose of [4-14C,1-3H]cholecalciferol (0.5,ug) was given to vitamin D-deficient chicks, the subcellular distribution was studied. At 24h after dosing, the nuclear fraction contained 27% and the supernatant fraction had 67% of total 14C recovered in the bone filtrate. When the 14C in the residual bone fragments was included, the nuclear fraction contained up to 35% of the total radioactivity in the bone. 5. The subcellular distribution pattern of individual vitamin D metabolites indicated that the purified nuclear fraction concentrated the polar metabolite, which lost 3H at C-1, so that 77% of the radioactivity could be accounted for by 1,25-dihydroxycholecalciferol. The supernatant fraction contained smaller amounts of 1,25-dihydroxycholecalciferol (9%), with 66% of 25-hydroxycholecalciferol forming the major metabolite, corresponding to its concentration found in blood at 24h. 6. The preferential accumulation of 1,25-dihydroxycholecalciferol in the nuclear fraction and the overall pattern of other metabolites, found previously in intestinal tissue, suggests a similar mechanism of action in bone to that postulated for the intestinal cell in calcium translocation.
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Since the preparation of radioactive vitamin D (Callow, Kodicek & Thompson, 1966; Neville & DeLuca, 1966) DeLuca, 1970) , though it is now apparent that it is a precursor of a further hormone-like metabolite which had an oxygen function introduced at C-1 (Lawson, Wilson & Kodicek, 1969a,b) . Lawson, Fraser, Kodicek, Morris & Williams (1971a) have identified the polar metabolite as la,25-dihydroxycholecalciferol produced by the kidney only from 25-hydroxycholecalciferol (Fraser & Kodicek, 1970 ). It appears to be identical with the unidentified polar fractions described as 'peak 4B' (Haussler, Myrtle & Norman, 1968) and with peak V in intestinal extracts (Cousins, DeLuca, Suda, Chen & Tanaka, 1970a) . It was found that 1,25-dihydroxycholecalciferol obtained in vitro from kidney preparations (Lawson et al. 1971a ) and the 147 polar material from intestinal tissue (Kodicek, Lawson & Wilson, 1970; Myrtle & Norman, 1971; Haussler, Boyce, Littledike & Rasmussen, 1971) were several times more active than cholecalciferol or 25-hydroxycholecalciferol in stimulating intestinal calcium transport. Only very small and limited amounts (<0.3ng/g of tissue) of 1,25-dihydroxycholecalciferol are produced from precursors in vivo and the identification was accomplished by using doubly labelled [4-14C,1-3H]cholecalciferol which lost its tritium on hydroxylation at C-1 (Lawson et al. 1969a,b; Kodicek, 1970a,b; Lawson, Pelc, Bell, Wilson & Kodicek, ] (Haussler & NormaI, 1967; Lawson et al. 1969b Lawson et al. , 1971b .
Similar investigations on bone have been hampered by the technical difficulties of preparing tissue. In the present study methods of preparation of bone components were developed and applied to the study of the time-course and subcellular distribution of vitamin D and its metabolites in chicken bonie.
EXPERIMENTAL
Animals. Day old 'Chunky' chicks (Sterling Poultry Services Ltd., Welwyn Garden City, Herts., U.K.) were fed on the vitamin D-defiaient diet and supplements as described by Lawson et al. (1969a) and were used after 4 weeks, when they were vitamin D-deficient. The 4-6-week-old chicks were injected intracardially with 0.51Ag (20 i.u.) of [4-14C,1,2-3H2]-or [4-14C,1-3H]-cholecalciferol in 0.2ml of propylene glycol. The 3H/14C specific radioactivity ratios of the two forms of labelled vitamin D were 11.7 and 6.6 respectively. The birds were killed after periods of 3, 6, 9, 12, 18 and 24h, blood was collected from each group and the tibiae were immediately freed from muscle. The perichondrium of the proximal epiphysis was trimmed and the articular cartilage peeled from the epiphyseal cartilage. The epiphyseal growth cartilage was separated from the metaphyseal bone by fracturing through the zone of provisional calcification (a natural cleavage plane). The metaphysis was separated from the diaphysis at the proximal limit of the marrow cavity. The epiphyseal growth cartilage, metaphysis and diaphysis were blotted free of blood and marrow and placed into separate 25 ml volumes of water at 00C. Each of the three bone components was weighed, chopped with scissors and scalpel, and finally homogenized in an MSE model 7700 homogenizer.
Subcellular distribution. Vitamin D-defiient chioks (20) were injeoted as before with 0.5,ug (20 i.u.) of [4-"4C,1-3H]cholecalciferol having a 3H/14C specific radioactivity ratio of 6.6. Metaphyses and diaphyses were removed and weighed in cold 0.25x-sucrose in TKM buffer [60mM-tris-HCl(pH7.5)-25mx-KCl-5mM-MgCl2]. These oombined bone components were repeatedly ground at 40C with a mincer fitted with openings down to 3/32in. This finely minced bone was suspended in 0.25M-suorose and filtered through nylon bolting cloth (St Martins lON). Nuclear, mitochondrial, microsomal and soluble subcellular fractions were prepared by a modified method of Schneider & Hogeboom (1950) , as described by Wilson, Lawson & Kodicek (1967) as follows. The filtrate was centrifuged for 10min at 800g and the nuclear-debris pellet resuspended and washed three times with 0.32M-sucrose in TKM buffer. For further purification, this pellet was resuspended in lOml of 0.32M-sucrose, mixed slowly with 80ml of 2.4M-sucrose and centrifuged for 1 h at 53500g in a Spinco SW 25.1 rotor to obtain purified nuclei (Lawson, Wilson, Barker & Kodicek, 1969c 1,25-DIHYDROXY-VITAMIN D IN BONE CELL NUCLEI specific radioactivity ratio; f, correction factor of 100/85, allowing for the distribution of 3H in the a position (85%) from which the loss of 3H occurred (Bell & Kodicek, 1970) .
RESULTS
Total radioactivity of bone components with time after injection of [4-14C,1,2-3H2]cholecalciferol. Fig.  1 shows the total d.p.m. of 14C/mg of DNA extracted from each bone component as a function oftime after dosing. The average amount of DNA/g for each bone component is shown in Table 1 .
At all time-periods the amount of 14C/mg of DNA was greatest in the metaphysis and diaphysis and least in the epiphysis. The peak of radioactivity in the metaphysis and diaphysis was reached at 6h, followed by a rapid decrease, particularly in the metaphysis. The peak of radioactivity in the epiphysis was slightly delayed and less pronounced. It is most likely that the timecourse of 140 incorporation depends on the relative blood supply, which is abundant in the trabecular bone of the metaphysis, but is somewhat limited in the epiphysis. After 9h, when the effect of difference in blood supplies had disappeared, the timecourse of 140 radioactivity was, excepting the epiphysis, essentially the same. Between 18 and (Fig. 2a) and diaphysis (Fig. 2b ) the cholecalciferol concentration is seen to decrease from 3h onwards. This reflects the decreasing concentrations of cholecalciferol in the blood shown in Fig. 2(d) indicating that bone shows little ability to actively retain cholecalciferol. 25-Hydroxycholecalciferol was the major contributor to the 6h peak observed in the curve of total 14C radioactivity ( Fig. 1) and its concentration also-follows the amounts found in blood (Fig. 2d) . The more polar metabolites of vitamin D reach a maximum concentration at 6-9h in the metaphysis and 9-12h in the diaphysis. Since chicken blood contains only very small amounts of the polar metabolites (Lawson et al. 1971a) , this appearance of relatively large amounts in bone suggests a high binding affinity.
The epiphysis (Fig. 2c) showed a similar distribution pattern of metabolites, but at markedly lower concentrations. The peak of the curves shifted to later times, with vitamin D reaching its maximum concentration at 6h. This might have been caused by thelimited blood circulation within the epiphysis.
In this experiment, it was found that the changes of 3H/14C ratios after [4-14C,1,2-3H2]cholecalciferol treatment were associated with greater errors and had little significance in view of the relatively small amounts of radioactivity recovered in the tissues examined, and also because of the relatively small change in the ratio to be expected from the tritium distribution (Bell & Kodicek, 1970) . Therefore, no calculation of the tritium-deficient polar substance was made and in the subsequent experiments, dosage with [4-14C,1-3H]cholecalciferol was preferred.
Vitamin D metabolites in bone component8. Table  2 shows the distribution of vitamin D and its metabolites 24h after dosing with 0.5,ag of [4-14C,1-3H]-cholecalciferol. It can be seen that 25-hydroxycholecalciferol accounted for about 60% of the recovered 14C radioactivity in all three bone components. The polar peak P, containing 1,25-dihydroxycholecalciferol, ranged from 26 to 35% and the rest of 14C radioactivity was found in the tibia in the -cholecalciferol and ester region. The doubly labelled cholecalciferol, with 3H in position C-1 only, should have allowed for an improved measure of the tritium-deficient material in-peak P. However, considerable difficulties were encountered in obtaining reliable 3H/14C ratios due to excessive trailing, particularly in the more polar regions. T.l.c. fractions T.l.c. fractions Fig. 3 . Thin-layer chromatographic distribution of vitamin D metabolites in the lipid extracts of (a) bone cell nuclei, (b) supernatant fraction, (c) residual bone and (d) blood from vitamin D-deficient chicks 24h after a 0.51tg dose of [4-14C,1_3H]cholecalciferol. The silica gel G thin layer was developed with n-heptaneethyl acetate (1:1, v/v). The 3H/14C ratios are given in parentheses when the quantity of radioactivity allows reliable ratio calculations. The shading in the polar peak represents the amount of 1,25-dihydroxyoholecalciferol calculated from the change in the 3H/14C ratio (for calculations see text). D, Cholecalciferol; HCC, 25-hydroxycholecalciferol; P, peak P. the 3H/14C ratio from 6.6 to 1.3). The remaining 19% of the 14C was distributed among the cholecalciferol and 25-hydroxycholecaleiferol bands. The nuclear fractions from bone contain quantities of bone mineral which pass through the filter and sediment with nuclei. All attempts to remove this filtered mineral have resulted in proportional loss of nuclear DNA, but the mineral contamination did not interfere with subsequent procedures.
T.l.c. of the bone supematant fraction (Fig. 3b ) indicates that 67% of the 14C was present as 25-hydroxycholecalciferol and a further 12% in the 0c 0 polar band, of which 70% was defined as 1,25-dihydroxycholecalciferol (calculated from the change in the 3H/14C ratio of the polar band from 6.6 to 2.7). The chromatograms of bone supernatant, and of plasma at the same time period (Fig.  3d) , are almost identical except for the polar peak containing 1,25-dihydroxycholecalciferol. This further suggests that 25-hydroxycholecalciferol readily diffuses into and out of cells according to the extracellular concentration, whereas the polar metabolite has a stronger intracellular binding, particularly in the nucleus. Fig. 3(c) shows the thin layer chromatogram of the extract from the non-filtrable residual bone of the mince. The distribution pattern resembled that of the nuclear fraction (Fig. 3a) in that the major component was 1,25-dihydroxycholecalciferol (73%), but differed from it in containing somewhat greater amounts of cholecalciferol (9%) and 25-hydroxycholecalciferol (17%) . This non-filtrable fraction of the residual bone extract, in which a further 295d.p.m. of 14C was recovered, consisted mainly ofnuclear material, since it contained a further 50% of DNA found in the bone filtrate. Table 3 shows the subcellular distribution of total 14C in the bone filtrate, indicating that 27.4% of 140 was recovered in the nuclear fraction.
If the residual 14C in the non-filtrable bone material is taken into account, the recovery in the nuclear fraction could be as high as 35%. The distribution pattern of vitamin D metabolites in the nuclear fraction shows that they consist preferentially of 1,25-dihydroxycholecalciferol, accounting for almost all the radioactivity in the polar peak P. The supematant had 66.9% of 14C of the filtrate, consisting mainly of 25-hydroxycholecalciferol, while here the polar peak P was only a minor fraction; the latter, within the experimental error of the method of calculation, consisted almost entirely of 1,25-dihydroxycholecalciferol. If any other dihydroxy analogues were present, they were in negligible amounts.
DISCUSSION
The technique described above for subcellular fractionation of bone yielded consistently about 60-70% of the bone DNA in the nuclear fraction and 80-90% of the total 14C bone radioactivity in the subcellular fractions. It indicated that for these particular investigations there was no need to isolate bone cells first, as in the more elaborate preparation of Nichols & Rogers (1971) . This simple technique left about 10-20% of total bone 14C behind in the non-filtrable residual bone material. This radioactivity appeared to be mainly, but not entirely, nuclear material. The reason for this retention is not clear, but the incomplete yield will depend on the structural properties of bone with the occlusion of bone cells in the mineral matrix.
The (Lawson et al. 1969b (Lawson et al. , 1971b Cousins et al. 1970a) .
In rachitic chick and rat bone (Lawson et al. 1969b) , after a dose of [4-14C,1-3H]cholecalciferol or 25-hydroxy[4-14C,1-3H]cholecalciferol, about 20% of the bone 14C radioactivity was found in peak P, with a significantly lowered 3H/14C specific radioactivity ratio, and is now identified as 1,25-dihydroxycholecalciferol (Lawson et al. 1971b Cousins, DeLuca & Gray (1970b) in the fraction they termed peak V, which is identical with peak P under certain conditions. Our results agree with these findings and, further, show that peak P or peak V in bone consists almost entirely of 1,25-dihydroxycholecalciferol. Our present results give further evidence of the localization of vitamin D metabolites in bone anatomical components (i.e. epiphysis, metaphysis and diaphysis) and add new information regarding the specific distribution pattern of vitamin D metabolites in subcellular fractions of bone. In particular, they demonstrate, by the use of doubly labelled cholecalciferol, the specific accumulation of 1,25-dihydroxycholecalciferol in bone cell nuclei. Because small amounts of 1 ,25-dihydroxycholecalciferol can be accumulated in the cell nuclei of intestinal tissue, and also because of its effects on nuclear metabolism (Lawson et al. 1969a,b; Hallick & DeLuca, 1969; Norman, 1968; Stohs, Zull & DeLuca, 1967) , an active role in calcium transport mechanisms has been postulated for this metabolite (see Kodicek et al. 1970) . The similar distribution of the metabolite in bone cells leads us to suggest that 1,25-dihydroxycholecalciferol has a similar role in this tissue.
21,25-Dihydroxycholecalciferol has been identified in the plasma of pigs given large amounts of cholecalciferol ). This metabolite, although less active than cholecalciferol in intestinal transport and the cure of rickets, was as active as 25-hydroxycholecalciferol in the mobilization of bone mineral. Similarly a further polar metabolite was identified as 25,26-dihydroxycholecalciferol (Suda, DeLuca, Schnoes, Tanaka & Holick, 1970b ), 152 1971 Vol. 125
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which was virtually inactive in mobilization of bone calcium and cure of rickets, but had some activity in intestinal calcium transport. The specific localization of these two compounds in cells of target organs has so far not been reported. As to their involvement in bone metabolism these derivatives of cholecalciferol can account for only a small proportion of the polar metabolites in bone cells under our conditions, if indeed they are present at all. 25-Hydroxycholecalciferol was the main constituent of our supematant fraction. It was virtually absent in the bone-cell nuclei, where the major metabolite was 1,25-dihydroxycholecalciferol. In view of the scarcity of information concerning the exact mechanism of bone formation and resorption, the question whether 25-hydroxycholecalciferol has, under physiological conditions, a direct role to play in bone metabolism in vivo, has to await further studies. This is particularly important, since Trummel, Raisz, Blunt & DeLuca (1969) found a direct effect on calcium release from bone in vitro, despite the fact that no 1,25-dihydroxycholecalciferol could have been present.
